Table 1.
Population Distribution, % (SE)a |
Received Treatment |
Distribution of Treatment, % (SE)c | Visits, Mean (SE), No.c | Distribution of Visits, % (SE)c | |||
---|---|---|---|---|---|---|---|
Subsample | % (SE)a | No.b | No.d | ||||
Any 12-mo DSM-IV/CIDI disorder | 27.5 (0.9) | 39.9 (1.0) | 2392 | 61.2 (1.5) | 16.5 (1.0) | 69.0 (3.3) | 1000 |
Lifetime but not 12-mo DSM-IV/CIDI disorder | 20.7 (0.4) | 18.3 (1.1) | 1575 | 21.1 (1.2) | 13.8 (1.7) | 19.9 (2.1) | 316 |
Any other indicator of possible neede | 13.7 (0.5) | 12.7 (1.7) | 633 | 9.7 (1.2) | 8.4 (1.9) | 5.5 (1.2) | 100 |
No indicator of potential need | 38.1 (1.1) | 3.8 (0.6) | 1092 | 8.0 (1.1) | 10.3 (4.8) | 5.6 (2.5) | 62 |
Total sample | 100 | 17.9 (0.7) | 5692 | 100 | 14.7 (0.8) | 100 | 1478 |
Significancef | NA | χ⅔=467.5 | NA | F3,1473 = 5.2 | NA |
Abbreviations: CIDI, Composite International Diagnostic Interview; NA, not applicable.
Percentages are based on weighted numbers of respondents in each subsample.
Unweighted number of respondents in each subsample.
Estimates are based on the weighted numbers of respondents in treatment in each subsample.
Unweighted number of respondents in treatment in each subsample.
Subthreshold 12-month diagnosis, 12-month major stressful event, or lifetime hospitalization for a mental health or substance use problem.
Significant association with the gradient at P<.05, 2-sided test.